• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-丙内酯处理会损害感染狂犬病病毒的BHK-21细胞残留DNA的生物活性。

Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.

作者信息

Morgeaux S, Tordo N, Gontier C, Perrin P

机构信息

WHO Collaborating Centre for Reference and Research on Rabies, Institut Pasteur, Paris, France.

出版信息

Vaccine. 1993;11(1):82-90. doi: 10.1016/0264-410x(93)90343-v.

DOI:10.1016/0264-410x(93)90343-v
PMID:8427040
Abstract

The effects of beta-propiolactone (BPL), an alkylating and virus inactivating agent, on the structural and in vitro biological properties of different DNA preparations from BHK-21 cells were investigated. Both uninfected and rabies virus-infected cells were used. Purified cellular DNA (celDNA) was used as the reference, and supernatants from infected cells were treated with BPL. For structural and biological studies three types of DNA preparation were tested: celDNA; purified DNA from cell (infected or uninfected) supernatant (pcsDNA) with or without BPL treatment; and residual cell DNA present in purified rabies virus (inactivated or not) preparations. Rabies infection and BPL (diluted 1:4000) treatment induced modifications in the structure of the three DNA types, including strand breaks and nicks. The damage to the DNA structure by BPL modifies the biological properties of the pcsDNA appraised by its ability to serve as the template in vitro for different polymerases. When rabies virus was inactivated with BPL diluted 1:1000 the DNA damage increased dramatically: small double-stranded DNA fragments (50-200 base pairs) were generated which could not function as templates for polymerases.

摘要

研究了烷基化和病毒灭活剂β-丙内酯(BPL)对来自BHK-21细胞的不同DNA制剂的结构和体外生物学特性的影响。使用了未感染和感染狂犬病病毒的细胞。以纯化的细胞DNA(celDNA)作为对照,并用BPL处理感染细胞的上清液。为了进行结构和生物学研究,测试了三种类型的DNA制剂:celDNA;来自细胞(感染或未感染)上清液的纯化DNA(pcsDNA),有或没有BPL处理;以及纯化的狂犬病病毒(灭活或未灭活)制剂中存在的残留细胞DNA。狂犬病感染和BPL(稀释1:4000)处理导致三种DNA类型的结构发生改变,包括链断裂和切口。BPL对DNA结构的损伤改变了pcsDNA的生物学特性,通过其作为不同聚合酶体外模板的能力来评估。当用稀释1:1000的BPL灭活狂犬病病毒时,DNA损伤急剧增加:产生了小的双链DNA片段(50-200个碱基对),这些片段不能作为聚合酶的模板。

相似文献

1
Beta-propiolactone treatment impairs the biological activity of residual DNA from BHK-21 cells infected with rabies virus.β-丙内酯处理会损害感染狂犬病病毒的BHK-21细胞残留DNA的生物活性。
Vaccine. 1993;11(1):82-90. doi: 10.1016/0264-410x(93)90343-v.
2
Inactivation of DNA by beta-propiolactone.β-丙内酯对DNA的灭活作用。
Biologicals. 1995 Sep;23(3):207-11. doi: 10.1006/biol.1995.0034.
3
In vitro inactivation of the rabies virus by ascorbic acid.抗坏血酸对狂犬病病毒的体外灭活作用。
Int J Infect Dis. 2004 Jan;8(1):21-5. doi: 10.1016/j.ijid.2003.09.002.
4
Zonal-centrifuged human diploid cell rabies vaccine.区带离心人二倍体细胞狂犬病疫苗
Dev Biol Stand. 1976;37:267-71.
5
Effect of inactivated viral vaccines (human) on frequency of micronuclei in bone marrow erythrocytes of mice.灭活病毒疫苗(人用)对小鼠骨髓红细胞微核频率的影响
Indian J Exp Biol. 1991 Jul;29(7):683-5.
6
[Potency studies of sample rabies vaccine, inactivated by beta-propiolactone].[用β-丙内酯灭活的狂犬病疫苗样品的效价研究]
Turk Hij Tecr Biyol Derg (1961). 1976;36(2):172-88.
7
Preparation of human rabies vaccine in VERO cell culture using a microcarrier system.使用微载体系统在VERO细胞培养物中制备人用狂犬病疫苗。
Braz J Med Biol Res. 1993 Dec;26(12):1305-17.
8
Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine.经色谱纯化的Vero细胞狂犬病疫苗在成人中的免疫原性、安全性及批次一致性:一项与人二倍体细胞狂犬病疫苗对比的随机双盲试验
Vaccine. 2001 Sep 14;19(32):4635-43. doi: 10.1016/s0264-410x(01)00238-9.
9
The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine.特异性IgE和β-丙内酯在人二倍体细胞狂犬病疫苗加强剂量引发的反应中的作用。
J Allergy Clin Immunol. 1987 Dec;80(6):861-8. doi: 10.1016/s0091-6749(87)80278-6.
10
Immunogenicity of rabies virus inactivated by -propiolactone, acetylethyleneimine, and ionizing irradiation.用β-丙内酯、乙烯亚胺和电离辐射灭活的狂犬病病毒的免疫原性。
Appl Microbiol. 1972 May;23(5):914-8. doi: 10.1128/am.23.5.914-918.1972.

引用本文的文献

1
Immunogenicity, Efficacy and Twelve-Month Storage Stability Studies of a Lyophilized Rabies mRNA Vaccine.冻干狂犬病信使核糖核酸疫苗的免疫原性、效力及十二个月储存稳定性研究
Vaccines (Basel). 2025 Jul 10;13(7):743. doi: 10.3390/vaccines13070743.
2
Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX.在禽类悬浮细胞系 AGE1.CR.pIX 中开发高效兽用狂犬病疫苗生产工艺。
BMC Biotechnol. 2022 Jun 17;22(1):17. doi: 10.1186/s12896-022-00747-5.
3
derived hyaluronic acid and bacillus Calmette-Guérin purified proteins as immune enhancers to rabies vaccine and related immuno-histopathological alterations.
源自透明质酸和卡介苗纯化蛋白作为狂犬病疫苗的免疫增强剂及相关免疫组织病理学改变。
Clin Exp Vaccine Res. 2021 Sep;10(3):229-239. doi: 10.7774/cevr.2021.10.3.229. Epub 2021 Sep 30.
4
Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines.单磷酰脂质 A(MPLA)是一种有效的狂犬病灭活疫苗佐剂。
Viruses. 2019 Dec 3;11(12):1118. doi: 10.3390/v11121118.
5
Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors.评价无血清培养基 MDSS2 在生物反应器中生产脊髓灰质炎病毒在vero 细胞上的应用。
Cytotechnology. 1997 Nov;25(1-3):35-44. doi: 10.1023/A:1007999313566.
6
Validation of the safety of MDCK cells as a substrate for the production of a cell-derived influenza vaccine.验证MDCK细胞作为生产细胞源流感疫苗基质的安全性。
Biologicals. 2010 Sep;38(5):544-51. doi: 10.1016/j.biologicals.2010.04.003.
7
Safety for vaccine(e)s.疫苗的安全性。
Cytotechnology. 2000 Nov;34(3):181-3. doi: 10.1023/A:1008160817560.
8
A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects.实验性狂犬病中的一种新型免疫刺激复合物(PICKCa):抗病毒及佐剂效应
Arch Virol. 1993;131(3-4):307-19. doi: 10.1007/BF01378634.